Andrew Savadelis Bio
Strategic and Operational Excellence:
Andrew Savadelis is a senior executive with demonstrated success in finance, strategy, operations, planning and sales in public, private and multinational companies. He has served in the CFO capacity in both public and private organizations, effectively as the COO in several companies, and on the audit committee as a Board member of a public biotech company. He has successfully completed private, public and IPO financings in both growth and turnaround companies.
As CFO of AE Polysilicon Corporation, Andrew most recently worked with the Department of Energy to negotiate a $250 million loan guarantee as part of a $500+ million project for a high tech chemical plant through the DOE’s loan guarantee program. He also secured significant tax credits through both federal and state programs. Andrew has directed and managed financial, accounting, human resources, investor and IT activities in high tech and biotech companies. His experience also includes significant cash management including managing a $2.4 billion cash portfolio and worldwide cash flows for Bristol-Myers Squibb.
Andrew is adept at identifying strategic and operational issues and implementing optimal solutions. He has extensive experience in M&A and strategic alliance negotiations as well as raising debt and equity financings for both public and private companies. For example, he deployed new strategic directions with detailed operational follow through to ensure the successful turnaround of a biotech company which increased the market capitalization of that company by 600% to over $130 million in less than nine months.
Prior to earning his M.B.A., Andrew provided IT and general management consulting for industrial and wholesale clients. Andrew analyzed client businesses and implemented full systems solutions to automate and streamline operations.
Andrew earned his B.S. in biology from Albright College and his M.B.A. from Cornell University.